KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-33.86%
↑ 15% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive declineDecelerating
Average
-39.89%
Historical baseline
PeriodValue
2025-33.86%
2024-26.67%
2023-14.76%
2022-66.80%
2021-42.90%
2020-35.93%
2019-59.42%
201816.27%
2017-47.15%
2016-87.67%